|
Volumn 17, Issue 14, 2007, Pages 3925-3929
|
2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: Orally bioavailable compounds
|
Author keywords
1,3 Thiazine; Cannabinoid receptor agonist; CB1; CB2; Oral bioavailability; Pain; Pharmacokinetic profile
|
Indexed keywords
1,3 THIAZINE DERIVATIVE;
5,6 DIHYDRO 4H 1,3 THIAZINE DERIVATIVE;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR AGONIST;
UNCLASSIFIED DRUG;
ANALGESIC ACTIVITY;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
INFLAMMATION;
NONHUMAN;
PAIN;
RECEPTOR AFFINITY;
STRUCTURE ACTIVITY RELATION;
ADMINISTRATION, ORAL;
BIOLOGICAL AVAILABILITY;
RECEPTORS, CANNABINOID;
THIAZINES;
|
EID: 34250304618
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2007.04.099 Document Type: Article |
Times cited : (39)
|
References (4)
|